Details for Patent: 8,846,066

Which drugs does patent 8,846,066 protect, and when does it expire?

Patent 8,846,066 protects KYBELLA and is included in one NDA.

This patent has seventy-eight patent family members in twenty-five countries.

Summary for Patent: 8,846,066

Title:	Methods and related compositions for reduction of fat and skin tightening
Abstract:	Compositions and methods useful in the reduction of localized fat deposits and tightening of loose skin in subjects in need thereof using pharmacologically active detergents are disclosed. The pharmacologically active detergent compositions can additionally include anti-inflammatory agents, analgesics, dispersion or anti-dispersion agents and pharmaceutically acceptable excipients. The pharmacologically active detergent compositions are useful for treating localized accumulations of fat including, for example, lower eyelid fat herniation, lipodystrophy and fat deposits associated with cellulite and do not require surgical procedures such as liposuction.
Inventor(s):	Kolodney; Michael S. (Santa Monica, CA), Rotunda; Adam M. (Los Angeles, CA)
Assignee:	The Regents of the University of California (Oakland, CA) Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (Torrance, CA)
Application Number:	13/917,450
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,846,066
Patent Claim Types: see list of patent claims	Use; Composition; Formulation;

Drugs Protected by US Patent 8,846,066

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Abbvie	KYBELLA	deoxycholic acid	SOLUTION;SUBCUTANEOUS	206333-001	Apr 29, 2015	AP	RX	Yes	Yes						METHOD FOR REDUCTION OF SUBMENTAL FAT

International Family Members for US Patent 8,846,066

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	E518565
Austria	E521355
Australia	2005245002
Canada	2567298